Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Kathrin Brenker has not added Biography.
If you are Kathrin Brenker and would like to personalize this page please email our Author Liaison for assistance.
Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Autoimmunity Feb, 2013 | Pubmed ID: 23039284
Max-Planck Institute for Immunobiology und Epigenetics
University of Freiburg
Kathrin Brenker1,2,3,
Kerstin Osthof1,4,
Jianying Yang1,3,
Michael Reth1,3,5
1, Max-Planck Institute for Immunobiology und Epigenetics,
2Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg,
3Centre for Biological Signaling Studies, BIOSS, University of Freiburg,
4, Albert-Ludwigs-Universität,
5Institute for Biology III (Mol. Immunology), Albert-Ludwigs-Universität
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.